Related Experiment Video
Updated: Jan 6, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment
Fares Jamal1, Nour B Odeh2, Mayar Husam Iyad Alatout3
1Division of Hematology and Oncology, Mayo Clinic, Phoenix, USA.
None:
Ulcerative colitis (UC) is a chronic inflammatory bowel disease influenced by genetic, immune, microbial, and environmental factors, with diet emerging as a key modifiable element. This narrative review examines how specific macronutrients, food additives, and dietary patterns affect UC pathogenesis, symptom control, and clinical outcomes. High intake of saturated fats, red and processed meats, and ultra-processed foods promotes dysbiosis and mucosal inflammation, while diets rich in fiber, resistant starches, and omega-3 fatty acids support gut barrier integrity and exert anti-inflammatory effects. The Mediterranean diet is associated with reduced disease activity, improved microbial diversity, and a lower incidence of pouchitis. Although the low-FODMAP diet can alleviate functional gastrointestinal symptoms, it lacks evidence for reducing inflammation and may adversely impact beneficial bacteria. Parenteral nutrition remains a valuable intervention in select cases with compromised oral or enteral intake. Micronutrient deficiencies, including iron, vitamin D, zinc, and magnesium, are common and should be routinely monitored. A personalized, dietitian-led approach that incorporates cultural preferences and digital tools may enhance dietary adherence and disease management. Further research is needed to define long-term effects of dietary interventions and integrate nutrition more fully into UC treatment algorithms.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

